Assessment of the Effectiveness of Health Education and Screening Test in Reducing Multiple Myeloma in the Middle-Elderly Nigerians – A Study Proposal Methodology
DOI:
https://doi.org/10.14738/jbemi.92.11916Keywords:
Multiple myeloma (MM), Health education, Awareness, Screening test, AssessmentAbstract
The developing countries including African union bear the highest global burden of cancer. Despite the increase, there is a huge gap on data management and case ascertainment of majority of these cancer diseases. This could be as a result of inability of the national cancer control agencies of most African union member countries to activate the priority areas of actions on cancer prevention. One of the malignant haematological diseases under-diagnosed in Nigeria is multiple myeloma. It causes end-stage organ failure including renal myeloma. This study proposal is a methodological overview of the strategic ways of assessing the impact of public health education and screening test in reducing the burden of multiple myeloma in Nigeria.
Two pairs of keywords (screening test and multiple myeloma), and (health education and multiple myeloma) were used as search strategy to identify the Problem, Intervention, Comparison, and Outcome (PICO) elements of the research question. PubMed, MedLine, Google Scholar, African Journal Online (AJOL), Cumulative Index Nursing and Allied Health Literature (CINAHL) were the database reviewed. This paper presented a synthesis of the reviewed articles and the expected outcomes of possible interventions on the burden of multiple myeloma disease in Nigeria. The study report was analysed and grouped according to the following categories: PICO research question on multiple myeloma, rationale for the study, study objective, study design, methodology, ethical considerations, data management and dissemination. Conclusion: This methodological study will serve as a public health safety measure for reducing the burden of multiple myeloma in Nigeria. The hallmark of the study outcome may be useful in crafting the surveillance epidemiological end-result (SEER) cancer statistics research database for multiple myeloma in Nigeria.
References
Bataille R, Harousseau JL. Multiple myeloma. N Eng J Med. 1997; 336: 1657-1664. https://doi.org/10.1056/NEJM199706053362307
International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. BMH. 2003; 121(5):749-757.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer Journal for Clin. 2002; 55(2):74-108. https://www.ncbi.nlm.nih.gov/pubmed/15761078
Landgren O, Weiss BM. (2009). Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: Support for genetic factors in pathogenesis. Leukemia, 23(10), pp 1691-97. https://doi.org/10.1038/leu.2009.134
Baughn LB, Pearce K, Larson D, et al. Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry. Blood Cancer J. 2018; 8:96. https://doi.org/10.1038/s41408-018-0132-1
Rajkumar SV, Dimopoulos MA, Palumbo A., et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15(12):e538-e548. https://doi.org/10.1016/S1470-2045(14)70442-5
Howlader, N., Noone, A.M., Krapcho, M. SEER Cancer Statistics Rev. 2018; 1975-2014. Bethesda: National Cancer Institute. https://seer.cancer.gov/archive/csr/1975_2014/
Nabalamba A, Chikoko M. Aging Population Challenges in Africa, AfDB Chief Economics Complex.2011: 1;1 Available at: https://reliefweb.int/sites/reliefweb.int/files/resources/Aging%20Population%20Challenges%20in%20Africadistribution.pdf
Sylla B, Wild CP. A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Can. 2012; 130(2):245-250. https://doi.org/10.1002/ijc.26333
Globocan. (2018). Global Cancer Observatory. http://gco.iarc.fr
Alao OO, Bazuaye GN, Halim N.K, Omoti CE. The epidemiology of Hematological malignancies at the University of Benin Teaching Hospital: A Ten-year Retrospective Study. Int J Epidemiol. 2010; 9(2):34-45.
Ferlay J, Shin HR, BrayF, Forman D, Mathers C, Parkin D. GLOBOCAN Nv1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10.2008. http://globocan.iarc.fr
Odunukwe NN, Madu AJ, Nnodu OE, et al. Multiple myeloma in Nigeria: A multi-centre epidemiological and biomedical study. Pan African Medical J. 2015; 22: 292. https://www.panafrican-medjournal.com/content/article/22/292/full
Nwabuko OC, Igbigbi EE, Chukwuonye II, Nnoli MA. Multiple myeloma in Niger Delta Nigeria: complications and the outcome of palliative interventions. CMAR. 2017:189-196. https://doi.org/10.2147/CMAR.S126136
Fasola FA, Eteng K, Akinyemi JO. Multiple myeloma: challenges of management in a developing country. Journal of Medicine & Medical Sc. 2008:397-403. http://www.interesjournal.org/JMMS
Omoti C, Halim NKD. Plasma Cell Myeloma in a Tertiary Center in Niger-Delta Region of Nigeria: Clinicoimmunologic Analysis. Pak. J. Med. Sci.2007; 23(1) pp. 27-32.
Leak SA, Mmbaga LG, Mkiwizu EW, Mapendo PJ, Henke O. Hematological malignancies in East Africa- Which cancers to expect and how to provide services. PLoS ONE 2020; 15(5): e0232848. https://doi.org/10.1371/journal.pone.0232848
Doumit M, Fares M. (2017). Knowledge of women towards breast cancer in Lebanon. American Journal of Hematology Oncol. 2017:13(7):21-28.
World Health Organization. Health promotion. World Health Organization, 2018; Ottawa. http://www.who.int/topics/health_promotion/en/
Glanz, K, Rimer BK, Viswanath K. Health behavior: Theory, research, and practice (5th edn). 2015; San Francisco, CA: Jossey-Bass.
Schmidth WP. Randomized and non-randomized studies to estimate the effect of community-level public health interventions: definitions and methodological considerations. Emerg Themes Epidemiol.2017; 14:9.
The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (2018). The Belmont Report [Online] HHS.gov. U.S. Department of Health and Human Services. Available at: https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html [Accessed 31 May 2020]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ogbonna Nwabuko, Raphael Edoka John
This work is licensed under a Creative Commons Attribution 4.0 International License.
